Cardiovascular risk reduction and diabetic kidney disease.

Sipahi continuing. While our findings are robust, they need to be replicated in other studies before they may be regarded as definitive. Before this study, there were no major safety worries with ARBs aside from their use in being pregnant and in individuals with chronic kidney or blockages of kidney arteries. Interestingly, previous animal research with ARBs have been negative for cancer development. In medicine, doctors must balance the huge benefits and risks of all drug and device therapies, said Dr. Daniel Simon, director of the Harrington-McLaughlin Heart & Vascular Institute at University Hospitals Case Medical Center and professor at Case Western Reserve University School of Medicine. We advise that individuals discuss the results of this study with their doctors since ARBs work agents in the treatment of high blood pressure and heart failure.Subsequently, 18 different labs spanning seven countries executed collaborative testing to confirm method robustness. Extra NF VALIDATION research of the Salmonella assay on seafood and vegetables along with digesting environment samples are anticipated in 2013. Related StoriesPoint-of-care diagnostics for EbolaNew programmed-death inhibitor screen assay kit for tumor research studiesBirmingham researchers identify how Salmonella attacks can result in life-threatening thrombosis We're proud to offer this important international validation to our worldwide customers, said Niki Montgomery, 3M Food Safety global marketing supervisor.